cmi_logo.png
[Latest] Global Flexible Plastic Packaging Market Size/Share Worth USD 293.7 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
22 mai 2024 12h30 HE | Custom Market Insights
Austin, TX, USA, May 22, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Flexible Plastic Packaging Market Size, Trends and Insights By Product Type...
AssemblyBio_logo_RGB.png
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
22 mai 2024 08h00 HE | Assembly Biosciences, Inc.
-- Preclinical data from both ABI-5366 and ABI-1179, Assembly Bio’s long-acting helicase-primase inhibitor candidates targeting recurrent genital herpes, featured in poster and oral presentations at...
DMR Logo.png
Malonic Acid Market Is Expected To Reach Revenue Of USD 169.0 Mn By 2033, At 3.2% CAGR: Dimension Market Research
21 mai 2024 13h41 HE | Dimension Market Research
New York, May 21, 2024 (GLOBE NEWSWIRE) -- Market Overview Global Malonic Acid Market size is expected to reach USD 127.1 million by 2024 and is further anticipated to reach USD 169.0...
Dalrada-Corporation-logo-400.png
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
21 mai 2024 08h45 HE | Dalrada Financial Corp.
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.
AERAMI THERAPEUTICS LOGO-VERTICAL- COLOR.png
Aerami Therapeutics Presents New Lung Deposition Modeling Data For AER-901 in Pulmonary Hypertension at the American Thoracic Society 2024 International Conference
20 mai 2024 17h00 HE | Aerami Therapeutics Inc
DURHAM, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare...
Sanofi new_logo.jpg
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2024
20 mai 2024 16h54 HE | Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi new_logo.jpg
Sanofi: Information concerning the total number of voting rights and shares - April 2024
20 mai 2024 16h54 HE | Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
lumos.png
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
20 mai 2024 16h05 HE | Lumos Pharma, Inc.
AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new...
Regeneron Logo.jpg
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
17 mai 2024 13h45 HE | Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and WASHINGTON, D.C., May 17, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Grace Sun, 16, of...
Phathom_Pharm_Logo_RGB.jpg
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
15 mai 2024 08h00 HE | Phathom Pharmaceuticals
First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD)1New research on Erosive gastroesophageal reflux disease (GERD)...